Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds.

Artikel i vetenskaplig tidskrift
Författare Stefano Sainas
Agnese C Pippione
Marta Giorgis
Elisa Lupino
Parveen Goyal
Cristina Ramondetti
Barbara Buccinnà
Marco Piccinini
Rodolpho C Braga
Carolina H Andrade
Mikael Andersson
Ann Christin Moritzer
Rosmarie Friemann
Stefano Mensa
Salam Al-Kadaraghi
Donatella Boschi
Marco L Lolli
Publicerad i European journal of medicinal chemistry
Volym 129
Sidor 287-302
ISSN 1768-3254
Publiceringsår 2017
Publicerad vid Institutionen för kemi och molekylärbiologi
Sidor 287-302
Språk en
Länkar dx.doi.org/10.1016/j.ejmech.2017.02...
www.ncbi.nlm.nih.gov/entrez/query.f...
Ämneskategorier Biofysik, Biokemi och molekylärbiologi, Strukturbiologi, Organisk kemi

Sammanfattning

A new generation of potent hDHODH inhibitors designed by a scaffold-hopping replacement of the quinolinecarboxylate moiety of brequinar, one of the most potent known hDHODH inhibitors, is presented here. Their general structure is characterized by a biphenyl moiety joined through an amide bridge with an acidic hydroxyazole scaffold (hydroxylated thiadiazole, pyrazole and triazole). Molecular modelling suggested that these structures should adopt a brequinar-like binding mode involving interactions with subsites 1, 2 and 4 of the hDHODH binding site. Initially, the inhibitory activity of the compounds was studied on recombinant hDHODH. The most potent compound of the series in the enzymatic assays was the thiadiazole analogue 4 (IC50 16 nM). The activity was found to be dependent on the fluoro substitution pattern at the biphenyl moiety as well as on the choice/substitution of the heterocyclic ring. Structure determination of hDHODH co-crystallized with one representative compound from each series (4, 5 and 6) confirmed the brequinar-like binding mode as suggested by modelling. The specificity of the observed effects of the compound series was tested in cell-based assays for antiproliferation activity using Jurkat cells and PHA-stimulated PBMC. These tests were also verified by addition of exogenous uridine to the culture medium. In particular, the triazole analogue 6 (IC50 against hDHODH: 45 nM) exerted potent in vitro antiproliferative and immunosuppressive activity without affecting cell survival.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?